Does NIFEDIPINE Cause Basal cell carcinoma? 30 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Basal cell carcinoma have been filed in association with NIFEDIPINE (Nifedipine). This represents 0.4% of all adverse event reports for NIFEDIPINE.
30
Reports of Basal cell carcinoma with NIFEDIPINE
0.4%
of all NIFEDIPINE reports
0
Deaths
15
Hospitalizations
How Dangerous Is Basal cell carcinoma From NIFEDIPINE?
Of the 30 reports, 15 (50.0%) required hospitalization, and 1 (3.3%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIFEDIPINE. However, 30 reports have been filed with the FAERS database.
What Other Side Effects Does NIFEDIPINE Cause?
Foetal exposure during pregnancy (927)
Drug ineffective (883)
Premature baby (791)
Maternal exposure during pregnancy (704)
Premature delivery (555)
Exposure during pregnancy (524)
Hypotension (505)
Off label use (474)
Drug hypersensitivity (459)
Completed suicide (431)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which NIFEDIPINE Alternatives Have Lower Basal cell carcinoma Risk?
NIFEDIPINE vs NILOTINIB
NIFEDIPINE vs NIMESULIDE
NIFEDIPINE vs NIMODIPINE
NIFEDIPINE vs NINTEDANIB
NIFEDIPINE vs NINTEDANIB ESYLATE